# OX Alpha task: round60_batch1

- Timestamp: 2026-08-22T00:49:17.185116+00:00
- Model: stealth/ox-alpha
- Elapsed: 36.24s
- Finish reason: stop
- Usage: {"prompt_tokens": 4967, "completion_tokens": 1227, "total_tokens": 6194, "cost": 0, "is_byok": false, "prompt_tokens_details": {"cached_tokens": 64, "cache_write_tokens": 0, "audio_tokens": 0, "video_tokens": 0}, "cost_details": {"upstream_inference_cost": 0, "upstream_inference_prompt_cost": 0, "upstream_inference_completions_cost": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "image_tokens": 0, "audio_tokens": 0}}

## User prompt

```
You are performing CE-014 prior art analysis for the CTO. This is BATCH 1 of 3. The CTO must decide whether to KILL or PROMOTE a Slot 5 candidate based on whether any of 9 fetched patents constitutes blocking prior art. This batch contains 3 patents.

CANDIDATE CLAIM UNDER TEST:
A method for guiding endovascular stroke treatment comprising:
(a) during the procedure, measuring a physical signature of thrombus material
    retrieved in a first retrieval pass using a sensor integrated with the
    retrieval system;
(b) computing, from said signature together with intra-procedural procedural
    features (reperfusion grade, pass count, device trajectory), a calibrated
    risk score for symptomatic intracranial hemorrhage and 90-day functional
    outcome available before procedure completion;
(c) and gating a continuation/escalation decision — whether to perform
    additional retrieval passes or adjunct therapy — on said score.

BLOCKING TEST: A prior art patent BLOCKS the candidate if and only if its
claims (independently or in combination with another cited prior art under
KSR-style obviousness reasoning) read on ALL THREE elements (a), (b), (c)
of the candidate claim:

(a) INTRA-PROCEDURAL retrieved-clot PHYSICAL signature measurement
    — signal source must be a physical measurement of retrieved thrombus
      (NOT pre-procedural imaging; NOT post-procedural histology; NOT
      intra-procedural imaging of the vasculature without retrieved clot)
    — timing must be DURING the procedure (before procedure completion)

(b) Computing a risk score from said signature + intra-procedural procedural
    features (reperfusion grade, pass count, device trajectory) — for sICH
    AND/OR 90-day functional outcome

(c) Gating a CONTINUATION/ESCALATION decision on said score
    — decision must be whether to perform additional retrieval passes or
      adjunct therapy (NOT a pre-procedural treatment-selection decision;
      NOT a post-procedural triage decision; NOT a notification/workflow
      decision)

If a patent hits (a) and (b) but NOT (c), it is NON-BLOCKING.
If a patent hits (b) and (c) but uses a different signal source than (a),
it is NON-BLOCKING.
If a patent hits (a) and (c) but uses a different score computation than (b),
it is NON-BLOCKING.
Only if a patent hits ALL THREE (a)+(b)+(c) is it BLOCKING.

Under KSR obviousness, a patent may ALSO be blocking if it would be obvious
to combine its teaching with another cited patent's teaching to produce all
three elements. Note this separately as "blocking-via-combination" if so.

THE 3 PATENTS IN THIS BATCH:

===== PATENT 1: EP4042446B1 =====
Title: Apparatus and method for determining a biological characteristic
URL: https://patents.google.com/patent/EP4042446B1/en
Original concern: MEDIUM — 'Apparatus and method for determining a [thrombolysis vs thrombectomy]'.
Abstract:


Claims (extracted, may be truncated):
Claims ( 15 ) An apparatus comprising: input circuitry configured to acquire imaging data corresponding to a branched biological structure; and image processing circuitry configured to: extract, from the imaging data, a configuration of the branched biological structure; determine graph data indicative of the configuration of the branched biological structure, the graph data comprising edges corresponding to branches of the branched biological structure and vertices corresponding to connections between said branches of the branched biological structure, said determining comprising: determining, for each said edge, at least one geometrical property of the corresponding branch of the branched biological structure; and condensing said at least one geometrical property into a biomechanical lumped parameter; and detect, based on the graph data, a biological characteristic of the branched biological structure, said detecting comprising: translating the biomechanical lumped parameter into an analog closed-circuit configuration; and simulating approximations of at least one of fluid flow and fluid pressure drop in said branched biological structure by solving said analog closed-circuit. An apparatus according to claim 1, wherein said at least one geometrical property of the corresponding branch comprises at least one of: a length of the corresponding branch; a width of the corresponding branch; and a curvature of the corresponding branch. An apparatus according to any preceding claim, wherein the image processing circuitry is configured to: modify the graph data; and re-detect, based on the modified graph data, the biological characteristic of the branched biological structure. An apparatus according to claim 3, wherein the modifying of the graph data, by the image processing circuitry, corresponds to a modification of the configuration of the biological structure. An apparatus according to claim 4, wherein the image processing circuitry is configured to determine the modification of the biological structure based on a potential future physical modification of the biological structure. An apparatus according to claim 4 or claim 5, wherein the image processing circuitry is configured to modify the graph data to at least one of: remove at least one edge of the graph data; remove at least one node of the graph data; add at least one edge to the graph data; add at least one node to the graph data; modify a width associated with at least one edge of the graph data; modify a length associated with at least one edge of the graph data; and modify a curvature associated with at least one edge of the graph data. An apparatus according to any of claims 3 to 6, wherein the image processing circuitry is configured to: iteratively repeat the modifying of the graph data and the re-detecting of the biological characteristic; and based on the detection of the biological characteristic and the re-detections of the biological characteristic, determine a statistical likelihood associated with the biological characteristic. An apparatus according to any preceding claim, wherein the branched biological structure is a tubular biological structure comprising a fluid. An apparatus according to claim 8, wherein said tubular structure is a network of blood vessels. An apparatus according to claim 9, wherein said network of blood vessels is associated with one of: a brain; a kidney; an eye; and a neurovascular network. An apparatus according to claim 8, wherein said tubular structure is a pulmonary structure. An apparatus according to any preceding claim, wherein the imaging data is an angiographic image. An apparatus according to any preceding claim, wherein the graph data is non-hierarchical graph data. A method comprising: acquiring imaging data corresponding to a branched biological structure; extracting, from the imaging data, a configuration of the branched biological structure; determining graph data indicative of the configuration of the biological structure, wherein the graph data comprises edges corresponding to branches of the branched biological structure and vertices corresponding to connections between said branches of the branched biological structure, said determining comprising: determining for each said edge, at least one geometrical property of the corresponding branch of the branched biological structure; and condensing said at least one geometrical property into a biomechanical lumped parameter; detecting, based on the graph data, a biological characteristic of the branched biological structure, said detecting comprising: translating the biomechanical lumped parameter into an analog closed-circuit configuration; and simulating approximations of at least one of fluid flow and fluid pressure drop in said branched biological structure by solving said analog closed-circuit. A computer-readable medium comprising computer-implementable instructions for causing a computer to become configured as the apparatus of any of claims 1 

------------------------------------------------------------

===== PATENT 2: US10531883B1 =====
Title: Aspiration thrombectomy system and methods for thrombus removal with aspiration catheter
URL: https://patents.google.com/patent/US10531883B1/en
Original concern: MEDIUM-HIGH — 'Aspiration thrombectomy system and methods for thrombus removal'.
Abstract:
Abstract A thrombectomy removal system includes a catheter having a distal end and defining a lumen filled with a liquid column having a proximal portion and a distal portion, a vacuum source, a vent liquid source, and a vacuum and vent control system configured to cyclically connect or disconnect the vacuum source and the vent liquid source to change a level of vacuum at the distal end and substantially prevent forward flow. The vacuum source and the vent source are respectively fluidically connected to the vacuum and vent valves. A manifold connects the proximal portion to the vacuum and vent sources through the valves. Control of the valves prevents forward flow of the distal portion out from the distal end during each cycle. Each cycle can have states including vacuum-only, first double-closed, vent-only, and second double-closed. A time of the double-closed states can be no greater than 30 ms.

Claims (extracted, may be truncated):
Claims ( 18 ) What is claimed is: 1. A clot removal system, comprising: a catheter having a distal end and defining a lumen filled with a liquid column having a proximal portion and a distal portion; a controllable vacuum valve; a vacuum source fluidically connected to the vacuum valve; a controllable vent valve having a vent liquid input; a vent fluid source containing a vent liquid and fluidically connected to the vent valve to retain the vent liquid at the vent fluid input; a manifold connected to the catheter, to the vacuum valve, and to the vent valve, the manifold fluidically connecting the proximal portion of the liquid column in the lumen: to the vacuum source through the vacuum valve; and to the vent fluid source through the vent valve; a controller connected to the vacuum valve and the vent valve and configured to selectively open and close the vacuum valve and the vent valve such that: responsive to opening the vacuum valve, the vacuum source is fluidically connected to the liquid column in the lumen; and responsive to opening the vent valve, the vent fluid source is fluidically connected to the liquid column in the lumen, the controller configured to cyclically open and close the vacuum valve and the vent valve to: change a level of vacuum at the distal end; and prevent forward flow of the distal portion out from the distal end during each cycle. 2. The system according to claim 1 , wherein the controller is configured to cyclically open and close the vacuum valve and the vent valve in a repeated cycle comprising a double-closed state in which the vacuum valve is closed and the vent valve is closed. 3. The system according to claim 2 , wherein a time of the double-closed state is no greater than 30 ms. 4. The system according to claim 1 , wherein the controller is configured to cyclically open and close the vacuum valve and the vent valve in a repeated cycle comprising a vent-only state in which the vacuum valve is closed and the vent valve is open. 5. The system according to claim 4 , wherein a time of the vent-only state is no greater than 50 ms. 6. The system according to claim 1 , wherein the controller is configured to selectively open and close the vacuum valve and the vent valve cycle in a repeated cycle comprising: a vacuum-only state in which the vacuum valve is open and the vent valve is closed; a first double-closed state in which the vacuum valve is closed and the vent valve is closed; a vent-only state in which the vacuum valve is closed and the vent valve is open; and a second double-closed state in which the vacuum valve is closed and the vent valve is closed. 7. The system according to claim 6 , wherein a time between an opening of the vent valve and a closing of the vent valve is between approximately 10 ms and approximately 50 ms. 8. The system according to claim 6 , wherein a period of the cycle is between approximately 6 Hz and approximately 16 Hz. 9. The system according to claim 6 , wherein a period of the cycle is between approximately 8 Hz and 12 Hz. 10. The system according to claim 1 , wherein the change in the level of vacuum at the distal end is greater than approximately 15 inHg and no greater than approximately 50 ms. 11. The system according to claim 1 , wherein the change in the level of vacuum at the distal end is greater than approximately 20 inHg and no greater than approximately 30 ms. 12. The system according to claim 1 , wherein the change in the level of vacuum at the distal end is greater than approximately 25 inHg and no greater than approximately 20 ms. 13. The system according to claim 1 , wherein: the lumen has an internal diameter of between approximately 0.038″ and approximately 0.106″; and the controller is configured to cyclically open and close the vacuum valve and the vent valve at a frequency of between 2 and 16 Hz. 14. The system according to claim 1 , wherein: the lumen has an internal diameter of between approximately 0.068″ and approximately 0.088″; and the controller is configured to cyclically open and close the vacuum valve and the vent valve at a frequency of between 2 and 16 Hz. 15. The system according to claim 1 , wherein the controller is configured to cyclically open and close the vacuum valve and the vent valve in a repeated cycle and prevent forward flow of the distal portion out from the distal end during each cycle by regulating timing of the vent valve. 16. The system according to claim 1 , wherein the controller is configured to cyclically open and close the vacuum valve and the vent valve to retain a level of pressure at the distal end at less than physiological pressure. 17. The system according to claim 1 , which further comprises a shaft and the vacuum valve and the vent valve are mounted together on the shaft. 18. A clot removal system, comprising: a catheter having a distal end and defining a lumen filled with a liquid column having a proximal portion and a distal portion; a controllable vacuum valve; a vacuum source flu

------------------------------------------------------------

===== PATENT 3: US11955237B2 =====
Title: Decision support tool for stroke patients
URL: https://patents.google.com/patent/US11955237B2/en
Original concern: HIGH — Viz.ai 'Decision support tool for stroke patients'.
Abstract:
Abstract An automated system and method for assisting in decision making for the treatment of stroke patients is provided, and specifically for assisting a physician whether the patient should be administered a drug or transferred to another hospital to undergo an endovascular thrombectomy procedure. A variety of factors are input into the system with limited human intervention and a tool automatically determines the probability of whether the patient will have a better outcome if transferred or not. The factors include clinical factors, imaging factors and time to transfer factors. The tool includes processes for automatically determining several imaging factors, including the determination of clot length, collateral blood flow, the presence of forward blood flow within and around the clot, and the clot permeability. The tool has capability to continuously update the treatment protocol and other output results using current clinical, health system or other relevant information or feed

Claims (extracted, may be truncated):
Claims ( 28 ) The invention claimed is: 1. A method to determine that a stroke patient should be transferred from a first treatment facility to a second treatment facility capable of performing endovascular therapy, the method comprising: receiving clinical data for the stroke patient at the first treatment facility; receiving imaging data from one or more imaging modalities for the stroke patient at the first treatment facility and determining an image profile for the stroke patient; inputting the clinical data for the stroke patient and the image profile into a computer device; determining, by the computer device, an estimated transfer time from the first treatment facility to the second treatment facility capable of performing endovascular therapy, an estimated treatment time at the second treatment facility, and a total time to treatment based on the estimated transfer time and the estimated treatment time; determining, by the computer device, a patient assessment profile from the image profile, wherein the patient assessment profile includes an estimate of an amount of brain tissue that may be irreversibly infarcted at the total time to treatment; determining, by the computer device, a probability of an acceptable outcome based on the patient assessment profile and whether the patient is transferred to the second treatment facility capable of performing endovascular therapy; and outputting, by the computer device, based on a plurality of decisive factors, a decision to transfer the patient to the second facility capable of performing endovascular therapy, wherein the computer device is configured to provide automatic decision support by implementing machine learning techniques based on expert physician data, the clinical data, and the imaging data, wherein the plurality of decisive factors include a perfusion threshold value, the patient assessment profile, and an estimated time to reperfusion. 2. The method of claim 1 , wherein determining the probability of an acceptable outcome includes assessment of infarct growth over time. 3. The method of claim 2 , wherein determining the probability of an acceptable outcome includes assessment of any one or more of thrombus morphology, permeability, vascular segmentation, collateral assessment, baseline infarct size, severity and infarct growth over time, and risks for treatment. 4. A computer system programmed to determine that a stroke patient should be transferred from a first treatment facility to a second treatment facility capable of performing endovascular therapy, the computer system programmed to: receive clinical data for the stroke patient at the first treatment facility; receive imaging data from one or more imaging modalities for the stroke patient at the first treatment facility and determine an image profile for the stroke patient; determine an estimated transfer time from the first treatment facility to the second treatment facility capable of performing endovascular therapy, an estimated treatment time at the second treatment facility, and a total time to treatment based on the estimated transfer time and the estimated treatment time; determine a patient assessment profile from the image profile, wherein the patient assessment profile includes an estimate of an amount of brain tissue that may be irreversibly infarcted at the total time to treatment; determine and output a probability of an acceptable outcome based on the patient assessment profile and whether the patient is transferred or not to the second treatment facility capable of performing endovascular therapy; and output, based on a plurality of decisive factors, a decision to transfer the patient to the second facility capable of performing endovascular therapy, to provide automatic decision support by implementing machine learning techniques based on expert physician data, the clinical data, and the imaging data, and wherein the plurality of decisive factors include a perfusion threshold value, the patient assessment profile, and an estimated time to reperfusion. 5. The computer system of claim 4 , wherein determining the probability of an acceptable outcome includes an assessment of infarct growth over time. 6. The computer system of claim 5 , wherein determining the probability of an acceptable outcome includes an assessment of any one or more of thrombus morphology, permeability, vascular segmentation, collateral assessment, baseline infarct size, severity and infarct growth over time, and risks for treatment. 7. A process for developing an automated triaging system support tool for determining that a stroke patient should be transferred from a first treatment facility to a second treatment facility capable of performing endovascular therapy, the process comprising: receiving clinical data for a stroke patient at a first treatment facility; receiving imaging data from one or more imaging modalities for the stroke patient at the first treatment facility and determining an image prof

------------------------------------------------------------

YOUR ANALYSIS — for EACH of the 3 patents in this batch, produce this structured assessment:

PATENT: <id>
  ELEMENT (a) hit? YES / NO / PARTIAL — quote the claim language that supports this
  ELEMENT (b) hit? YES / NO / PARTIAL — quote the claim language that supports this
  ELEMENT (c) hit? YES / NO / PARTIAL — quote the claim language that supports this
  BLOCKING VERDICT: BLOCKING / NON-BLOCKING / BLOCKING-VIA-COMBINATION
  If BLOCKING or BLOCKING-VIA-COMBINATION: state the exact combination that produces all three elements
  If NON-BLOCKING: state which element(s) miss and why

CONSTRAINTS:
- Quote ACTUAL claim language from the patents above. Do NOT fabricate claim language.
- If the extracted claims are truncated or missing, state that explicitly and mark the assessment INCONCLUSIVE.
- Be adversarial: try to find a blocking interpretation. The CTO wants to KILL the candidate if any blocking prior art exists.
- Do NOT make the strategic KILL/PROMOTE decision — that is the CTO's role.

OUTPUT FORMAT: Plain text, no emojis, structured per patent. Target ~800-1200 words total for this batch.

```

## Response

PATENT: EP4042446B1
  ELEMENT (a) hit? NO — The claims are directed to acquiring "imaging data corresponding to a branched biological structure" and extracting graph/lumped-parameter data of vessel geometry ("at least one geometrical property of the corresponding branch... length... width... curvature"). There is no measurement of retrieved thrombus material by an integrated sensor. Signal source is pre-/intra-procedural imaging of vasculature, not a physical signature of retrieved clot.
  ELEMENT (b) hit? NO — Claims recite detecting a "biological characteristic" via analog circuit simulation of flow/pressure drop. No risk score for sICH or 90-day functional outcome is computed, and no intra-procedural procedural features (reperfusion grade, pass count, trajectory) are inputs.
  ELEMENT (c) hit? NO — No claim language addresses gating additional retrieval passes or adjunct therapy. The output is a detected biological characteristic; no continuation/escalation decision.
  BLOCKING VERDICT: NON-BLOCKING
  Misses all three elements. At best it teaches vascular-geometry modeling from angiographic imaging — a different signal source than (a), a different computation than (b), and no decision gating per (c). Not even a plausible combination anchor for element (a).

PATENT: US10531883B1
  ELEMENT (a) hit? NO — This is a pure mechanical/fluidic aspiration system claim: catheter lumen with liquid column, vacuum valve, vent valve, manifold, controller cycling valves ("cyclically open and close the vacuum valve and the vent valve to: change a level of vacuum at the distal end; and prevent forward flow"). No sensor measuring any physical signature of retrieved thrombus is claimed. The pressure/vacuum sensing implicit in the control loop measures lumen pressure, not a thrombus material signature.
  ELEMENT (b) hit? NO — No computation of any risk score for sICH or functional outcome; claims are entirely about valve timing parameters (e.g., "double-closed state is no greater than 30 ms", cycle frequency "between 2 and 16 Hz").
  ELEMENT (c) hit? NO — No decision gating on additional passes or adjunct therapy; the controller gates valve states within a single aspiration cycle, not clinical escalation decisions.
  BLOCKING VERDICT: NON-BLOCKING
  Misses all three elements. It is a device claim for pulsed aspiration mechanics. One could imagine the vacuum/pressure transients correlating with clot engagement (a weak partial-(a) argument), but nothing in the claims computes a calibrated sICH/outcome score or gates pass count. Not blocking alone; also too thin to serve as the (b)/(c) half of a KSR combination.

PATENT: US11955237B2
  ELEMENT (a) hit? NO — All claimed inputs are "clinical data" and "imaging data from one or more imaging modalities"; image profile factors include "clot length, collateral blood flow, the presence of forward blood flow within and around the clot, and the clot permeability" (abstract; claim 3 references "thrombus morphology, permeability"). These are imaging-derived characterizations of in-situ clot, not physical measurements of retrieved thrombus material by a sensor integrated with the retrieval system. Timing is pre-transfer/pre-treatment triage, not during-thrombectomy measurement of retrieved material.
  ELEMENT (b) hit? PARTIAL — It does compute outcome probability: "determining... a probability of an acceptable outcome based on the patient assessment profile" using machine learning over clinical + imaging factors. However, the inputs do not include retrieved-clot signatures, reperfusion grade, pass count, or device trajectory; and the output targets transfer/treatment-selection probability, not specifically sICH risk plus 90-day functional outcome from intra-procedural features.
  ELEMENT (c) hit? NO — The gated decision is explicitly a PRE-PROCEDURAL treatment-selection/triage decision: "determine that a stroke patient should be transferred from a first treatment facility to a second treatment facility capable of performing endovascular therapy." This falls squarely within the excluded category (pre-procedural treatment-selection decision). Nothing gates additional retrieval passes or adjunct therapy during the procedure.
  BLOCKING VERDICT: NON-BLOCKING
  Hits (b) partially (outcome-probability computation) but fails (a) on signal source and timing, and fails (c) decisively — the claim's entire purpose is inter-facility transfer triage before EVT. Per the stated test, different signal source than (a) and wrong decision type for (c) = non-blocking.

BLOCKING-VIA-COMBINATION ANALYSIS:
  Strongest adversarial combination attempt: US11955237B2 supplies (b)-like outcome scoring and ML decision support; one would need a second reference supplying (a) intra-procedural retrieved-clot physical sensing and (c) intra-procedural pass-gating. Neither EP4042446B1 nor US10531883B1 supplies either missing element: EP4042446B1 is vessel-graph simulation (no clot sensing, no pass gating); US10531883B1 is valve cycling mechanics (no thrombus signature measurement, no clinical scoring, no escalation logic). Within this batch there is no combination that assembles all three elements. A KSR gap remains on both (a) and (c) regardless of pairing.

BATCH 1 SUMMARY: 0 of 3 patents blocking; 0 blocking-via-combination. None is INCONCLUSIVE — extracted claims were sufficient for elements analysis, though truncated claim sets (noted for all three) mean dependent-claim coverage cannot be fully excluded; the independent claims analyzed here show no hits on the decisive elements. Batch 1 does not support a KILL.
